Published in Cardiovascular Device Liability Week, June 15th, 2008
ACAM has played a strategic role in disseminating information about the trial, linking participants to study-sites, and providing information to its members and the public about this important study. Today, ACAM...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.